The University of Southampton
University of Southampton Institutional Repository

Mapping investments and published outputs in norovirus research: a systematic analysis of research funded in the United States and United Kingdom during 1997–2013

Mapping investments and published outputs in norovirus research: a systematic analysis of research funded in the United States and United Kingdom during 1997–2013
Mapping investments and published outputs in norovirus research: a systematic analysis of research funded in the United States and United Kingdom during 1997–2013
Background: Norovirus accounts for a considerable portion of the global disease burden. Mapping national or international investments relating to norovirus research is limited.

Methods: We analyzed the focus and type of norovirus research funding awarded to institutions in the United States and United Kingdom during 1997–2013. Data were obtained from key public and philanthropic funders across both countries, and norovirus-related research was identified from study titles and abstracts. Included studies were further categorized by the type of scientific investigation, and awards related to vaccine, diagnostic, and therapeutic research were identified. Norovirus publication trends are also described using data from Scopus.

Results: In total, US and United Kingdom funding investment for norovirus research was £97.6 million across 349 awards; 326 awards (amount, £84.9 million) were received by US institutions, and 23 awards (£12.6 million) were received by United Kingdom institutions. Combined, £81.2 million of the funding (83.2%) was for preclinical research, and £16.4 million (16.8%) was for translational science. Investments increased from £1.7 million in 1997 to £11.8 million in 2013. Publication trends showed a consistent temporal increase from 48 in 1997 to 182 in 2013.

Conclusions: Despite increases over time, trends in US and United Kingdom funding for norovirus research clearly demonstrate insufficient translational research and limited investment in diagnostics, therapeutics, or vaccine research.
infectious disease, norovirus, norwalk, investments, bibliometrics
0022-1899
S3-S7
Head, Michael
67ce0afc-2fc3-47f4-acf2-8794d27ce69c
Fitchett, Joseph R.
1eae456d-373c-428b-a276-353f0a75822e
Lichtman, Amos B.
ea31bee5-0e1f-4e61-b815-85d265dc1ebd
Soyode, Damilola T.
78810a8f-fda0-418d-982b-340ffa7b212e
Harris, Jennifer N.
f1344ff8-07a0-45ea-80f6-1dfcf9fe8e99
Atun, Rifat
20f14d3b-facf-4079-8566-eb6d13521a34
Head, Michael
67ce0afc-2fc3-47f4-acf2-8794d27ce69c
Fitchett, Joseph R.
1eae456d-373c-428b-a276-353f0a75822e
Lichtman, Amos B.
ea31bee5-0e1f-4e61-b815-85d265dc1ebd
Soyode, Damilola T.
78810a8f-fda0-418d-982b-340ffa7b212e
Harris, Jennifer N.
f1344ff8-07a0-45ea-80f6-1dfcf9fe8e99
Atun, Rifat
20f14d3b-facf-4079-8566-eb6d13521a34

Head, Michael, Fitchett, Joseph R., Lichtman, Amos B., Soyode, Damilola T., Harris, Jennifer N. and Atun, Rifat (2016) Mapping investments and published outputs in norovirus research: a systematic analysis of research funded in the United States and United Kingdom during 1997–2013. The Journal of Infectious Diseases, 213, supplement 1, S3-S7. (doi:10.1093/infdis/jiv366).

Record type: Article

Abstract

Background: Norovirus accounts for a considerable portion of the global disease burden. Mapping national or international investments relating to norovirus research is limited.

Methods: We analyzed the focus and type of norovirus research funding awarded to institutions in the United States and United Kingdom during 1997–2013. Data were obtained from key public and philanthropic funders across both countries, and norovirus-related research was identified from study titles and abstracts. Included studies were further categorized by the type of scientific investigation, and awards related to vaccine, diagnostic, and therapeutic research were identified. Norovirus publication trends are also described using data from Scopus.

Results: In total, US and United Kingdom funding investment for norovirus research was £97.6 million across 349 awards; 326 awards (amount, £84.9 million) were received by US institutions, and 23 awards (£12.6 million) were received by United Kingdom institutions. Combined, £81.2 million of the funding (83.2%) was for preclinical research, and £16.4 million (16.8%) was for translational science. Investments increased from £1.7 million in 1997 to £11.8 million in 2013. Publication trends showed a consistent temporal increase from 48 in 1997 to 182 in 2013.

Conclusions: Despite increases over time, trends in US and United Kingdom funding for norovirus research clearly demonstrate insufficient translational research and limited investment in diagnostics, therapeutics, or vaccine research.

Text
J Infect Dis.-2016-Head-S3-7.pdf - Version of Record
Restricted to Repository staff only
Request a copy

More information

Published date: 1 February 2016
Keywords: infectious disease, norovirus, norwalk, investments, bibliometrics
Organisations: CES General, Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 386490
URI: https://eprints.soton.ac.uk/id/eprint/386490
ISSN: 0022-1899
PURE UUID: 2e65c462-6bd1-4f5a-8c15-6f5670a8d06e
ORCID for Michael Head: ORCID iD orcid.org/0000-0003-1189-0531

Catalogue record

Date deposited: 01 Feb 2016 15:24
Last modified: 03 Dec 2019 01:33

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×